Evidence map›Paper›PMID 23628882›Full record

ArticlePediatric research2013

L-carnitine preserves endothelial function in a lamb model of increased pulmonary blood flow.

Shruti Sharma, Angela Aramburo, Ruslan Rafikov, Xutong Sun, Sanjiv Kumar, Peter E Oishi, Sanjeev A Datar, Gary Raff, Kon Xoinis, Gohkan Kalkan and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Metabolism in Pulmonary Hypertension.Annual review of physiology · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Shruti SharmaPulmonary Vascular Disease Program, Vascular Biology Center, Georgia Regents University, Augusta, GA, USA.
Angela Aramburo
Ruslan Rafikov
Xutong Sun
Sanjiv Kumar
Peter E Oishi
Sanjeev A Datar
Gary Raff
Kon Xoinis
Gohkan Kalkan
Sohrab Fratz
Jeffrey R Fineman
Stephen M Black
University of California, San Francisco · USAugusta University · USGeorgia Regents Medical Center · USMünchen Klinik · DEUniversity of California, Davis · US

Funding

Pediatric Critical Care Scientist Development ProgramK12HD047349 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HEATHER T. KEENAN, Kevin M Watt · 2004 to 2026
$17.0M
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORSR01HL061284 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FINEMAN, JEFFREY R · 1999 to 2016
$8.3M
PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENER01HL060190 · NHLBI · UNIVERSITY OF MONTANA · PI Stephen M Black · 1998 to 2026
$7.1M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
ROS in Pulmonary Hypertension: Role of ADMAR01HL067841 · NHLBI · UNIVERSITY OF MONTANA · PI BLACK, STEPHEN M · 2002 to 2011
$2.6M
Perinatal regulation of TGF-beta1 during vascular remodelingR01HL084739 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2007 to 2010
$1.5M
Vascular Dysfunction with Increased Pulmonary Blood Flow: A role for PPAR GammaK08HL086513 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OISHI, PETER ERIC · 2007 to 2010
$487k
Role of altered carnitine metabolism in perinatal endothelial dysfunctionR21HD057406 · NICHD · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2008 to 2009
$423k
NHLBI NIH HHS HL084739NHLBI NIH HHS HL60190NHLBI NIH HHS HL61284NHLBI NIH HHS HL67841NHLBI NIH HHS K08 HL086513NHLBI NIH HHS R01 HL060190NHLBI NIH HHS R01 HL061284NHLBI NIH HHS R01 HL067841NHLBI NIH HHS R01 HL084739NICHD NIH HHS R21 HD057406NICHD NIH HHS R21HD057406NICHD NIH HHS T32 HD049303
6 · The paper itself

Abstract

backgroundIn our model of a congenital heart defect (CHD) with increased pulmonary blood flow (PBF; shunt), we have recently shown a disruption in carnitine homeostasis, associated with mitochondrial dysfunction and decreased endothelial nitric oxide synthase (eNOS)/heat shock protein (Hsp)90 interactions that contribute to eNOS uncoupling, increased superoxide levels, and decreased bioavailable nitric oxide (NO). Therefore, we undertook this study to test the hypothesis that L-carnitine therapy would maintain mitochondrial function and NO signaling.

methodsThirteen fetal lambs underwent in utero placement of an aortopulmonary graft. Immediately after delivery, lambs received daily treatment with oral L-carnitine or its vehicle.

resultsL-Carnitine-treated lambs had decreased levels of acylcarnitine and a reduced acylcarnitine:free carnitine ratio as compared with vehicle-treated shunt lambs. These changes correlated with increased carnitine acetyl transferase (CrAT) protein and enzyme activity and decreased levels of nitrated CrAT. The lactate:pyruvate ratio was also decreased in L-carnitine-treated lambs. Hsp70 protein levels were significantly decreased, and this correlated with increases in eNOS/Hsp90 interactions, NOS activity, and NOx levels, and a significant decrease in eNOS-derived superoxide. Furthermore, acetylcholine significantly decreased left pulmonary vascular resistance only in L-carnitine-treated lambs.

conclusionL-Carnitine therapy may improve the endothelial dysfunction noted in children with CHDs and has important clinical implications that warrant further investigation.

Indexed as

AnimalsCarnitineEndometritisEndothelium, VascularFemaleHomeostasisHSP90 Heat-Shock ProteinsLungMitochondriaNitric OxideNitric Oxide Synthase Type IIIRegional Blood FlowSheepSuperoxidesCarnitineHSP90 Heat-Shock ProteinsNitric OxideNitric Oxide Synthase Type IIISuperoxides

Identifiers

PMID23628882
PMCPMC3709010
OpenAlexW2088256508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.